Cargando…

Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells

Growth hormone-releasing hormone (GHRH) and its receptors are expressed in a variety of human cancers, and have been involved in malignancies. GHRH antagonists (GHRHAnt) were developed to suppress tumor progression and metastasis. Previous studies demonstrate the involvement of reactive oxygen speci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubra, Khadeja-Tul, Akhter, Mohammad S., Apperley, Kaitlyn, Barabutis, Nektarios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762825/ https://www.ncbi.nlm.nih.gov/pubmed/36540765 http://dx.doi.org/10.3390/endocrines3040067

Ejemplares similares

Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs
por: Akhter, Mohammad S., et al.
Publicado: (2020)

An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration
por: Akhter, Mohammad S., et al.
Publicado: (2022)

Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption
por: Akhter, Mohammad S., et al.
Publicado: (2022)

Luminespib counteracts the Kifunensine-induced lung endothelial barrier dysfunction
por: Kubra, Khadeja-Tul, et al.
Publicado: (2020)

P53 deficiency potentiates LPS-Induced acute lung injury in vivo
por: Uddin, Mohammad A., et al.
Publicado: (2020)

Restoring the endothelial barrier function in the elderly
por: Barabutis, Nektarios, et al.
Publicado: (2021)

Elucidation of the Molecular Pathways Involved in the Protective Effects of AUY-922 in LPS-Induced Inflammation in Mouse Lungs
por: Akhter, Mohammad S., et al.
Publicado: (2021)

P53 is Subjected to Lipoteichoic Acid-Induced Phosphorylation in the Lungs
por: Kubra, Khadeja-Tul, et al.
Publicado: (2020)

Metformin in acute respiratory distress syndrome: An opinion
por: Uddin, Mohammad A., et al.
Publicado: (2021)

Tunicamycin Protects against LPS-Induced Lung Injury
por: Kubra, Khadeja-Tul, et al.
Publicado: (2022)

Effects of Heat Shock Protein 90 Inhibition In the Lungs
por: Uddin, Mohammad A., et al.
Publicado: (2020)

Growth hormone releasing hormone induces the expression of nitric oxide synthase
por: Barabutis, Nektarios, et al.
Publicado: (2011)

Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress
por: Uddin, Mohammad A., et al.
Publicado: (2021)

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines
por: Barabutis, N, et al.
Publicado: (2008)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Study on JV Virus in Patients with Colon Cancer Type Adenocarcinoma
por: Haghi Navand, Azadeh, et al.
Publicado: (2019)

Colocalization of connexin 36 and corticotropin-releasing hormone in the mouse brain
por: Westberg, Lars, et al.
Publicado: (2009)

SAT-603 Growth Hormone-Releasing Hormone (GHRH) Antagonists Stimulate Feeding in Mice
por: Leone, Sheila, et al.
Publicado: (2020)

Reactive Oxygen Species Link Gonadotropin-Releasing Hormone Receptor Signaling Cascades in the Gonadotrope
por: Terasaka, Tomohiro, et al.
Publicado: (2017)

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers
por: Perez, Roberto, et al.
Publicado: (2012)

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
por: Jungwirth, A., et al.
Publicado: (1997)

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
por: Villanova, Tania, et al.
Publicado: (2019)

Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin
por: Zhang, Chongxu, et al.
Publicado: (2019)

Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma
por: Gesmundo, Iacopo, et al.
Publicado: (2022)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
por: Chwalisz, Kristof
Publicado: (2023)

Reactive oxygen species and male reproductive hormones
por: Darbandi, Mahsa, et al.
Publicado: (2018)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
por: Asakawa, Jumpei, et al.
Publicado: (2018)

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
por: Rosario, Derek J., et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
por: Rzewuska, Anna Maria, et al.
Publicado: (2023)

Draft Genome Sequence of Chryseobacterium sp. JV274 Isolated from Maize Rhizosphere
por: Vacheron, Jordan, et al.
Publicado: (2017)

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
por: Trudeau, Vance L, et al.
Publicado: (2010)

Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
por: Guo, Jian, et al.
Publicado: (2010)

Structural Motif Descriptors as a Way To Elucidate the Agonistic or Antagonistic Activity of Growth Hormone–Releasing Hormone Peptide Analogues
por: Jeanne Dit Fouque, Kevin, et al.
Publicado: (2018)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
por: Hosein Rashidi, Batool, et al.
Publicado: (2019)

Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization
por: Kochhar, Puneet Kaur, et al.
Publicado: (2020)

Activity of the growth hormone‐releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis‐like granuloma
por: Zhang, Chongxu, et al.
Publicado: (2021)

Growth Hormone-Releasing Hormone in Diabetes
por: Fridlyand, Leonid E., et al.
Publicado: (2016)

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
por: Shebley, Mohamad, et al.
Publicado: (2019)

Placental polyp with arteriovenous malformation treated with a gonadotoropin-releasing hormone antagonist
por: Goda, Mayuko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_svk106ka8enguh46idui7g87oo